MRFF BioMedTech Incubator
Funds early-stage biomedical and health technology ventures in Australia through incubation and commercialization support.
The BioMedTech Incubator is an active sub-program within the MRFF Medical Research Commercialisation initiative, supporting early-stage commercialisation of biomedical and health technologies. It provides funding of up to A$33 million per incubator for SMEs, research organisations, and universities translating medical research discoveries into clinical practice. The program received A$50M over 2 years from 2022-23 and a further A$99M over 3 years from 2024-25. Delivered by MTPConnect (primary partner) in coordination with DoHDA. A focused Dementia and Cognitive Decline stream (A$50M over 2 years from 2023-24) runs in parallel. Applications via GrantConnect (grants.gov.au).
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.